In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist
- 9 August 2000
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 402 (1-2) , 45-53
- https://doi.org/10.1016/s0014-2999(00)00520-3
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- ORL1, a novel member of the opioid receptor familyPublished by Wiley ,2001
- Cardiovascular Effects of Nociceptin in Unanesthetized MiceHypertension, 1999
- Pertussis Toxin‐Insensitive Signaling of the ORL1 Receptor: Coupling to Gz and G16 ProteinsJournal of Neurochemistry, 1998
- [Phe1Ψ(CH2-NH)Gly2]-nociceptin-(1-13)NH2, a proposed antagonist of the nociceptin receptor, is a potent and stable agonist in the rat spinal cordNeuroscience Letters, 1998
- Characterization of nociceptin hyperalgesia and allodynia in conscious miceBritish Journal of Pharmacology, 1997
- Dissociation of affinity and efficacy in KOR‐3 chimerasFEBS Letters, 1996
- Orphanin FQ: A Neuropeptide That Activates an Opioidlike G Protein-Coupled ReceptorScience, 1995
- Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptorNature, 1995
- Intracerebroventricular injections in miceJournal of Pharmacological Methods, 1986
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973